Original Articles
Vol. 21 No. 2 (2026)
https://doi.org/10.3269/jptjtx80

IMPACT OF CHRONIC LIVER DISEASE ON BONE DENSITY IN CHILDREN: A DEXA SCAN STUDY

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: July 14 2026
0
Views
0
Downloads
Chronic liver disease, DEXA scan, bone density, children

Authors

Mohammad Fadhil Ibraheem
mohammedalqaisi@yahoo.com
College of Medicine, University of Baghdad, Iraq.
Jaafar Abdullah Hamzah
Children’s Welfare Teaching Hospital, Medical City Complex, Baghdad, Iraq.

Reduced bone density is a common complication of chronic liver disease (CLD) in both adults and children. Factors contributing to bone mineral deficits are dependent on the pathophysiology and severity of the underlying liver disease. This case-control study aims to assess the bone mineral density in children (4-13 years old) suffering from CLD, using a dual-energy X-ray absorptiometry (DEXA) scan. The study was conducted in the Children’s Welfare Teaching Hospital (Baghdad, Iraq) from 1 November 2023 to 1 November 2024. Bone mineral density has been assessed by DEXA scan for 78 patients and controls in the pediatric age group. The mean Z-score was −0.44 among patients and 0.45 among the control group. This difference was statistically significant (p=0.02). According to the DEXA scan Z-scores, bone mineral density was significantly lower among children with CLD. Bone mineral density was correlated with alkaline phosphatase (ALP) and the duration of disease. Although there was a difference in Z-score levels across different disease types, this difference did not reach statistical significance.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
1. Mahmoudi A, Sellier N, Reboul-Marty J, et al. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study. Clin Res Hepatol Gastroenterol 2011;35:731-7.
2. Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases. Clin Rev Allerg Immunol 2005;28:147-57.
3. Vargas AA, Acevedo JMP, Domingo IG, et al. Prevalence and Characteristics of Bone Disease in Cirrhotic Patients Under Evaluation for Liver Transplantation. Transplant Proc 2012;44:1496-8.
4. Guichelaar MMJ, Kendall R, Malinchoc M, et al. Bone mineral density before and after OLT: Long-term follow-up and predictive factors. Liver Transpl 2006;12:1390-402.
5. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res 2001;16:1658-64.
6. Olsen IE, Ittenbach RF, Rovner AJ, et al. Deficits in Size-Adjusted Bone Mass in Children with Alagille Syndrome. J Pediatr Gastroenterol Nutr 2005;40:76-82.
7. Kramer RA, Zemel BS, Arvay-Nezu JL, et al. Bone Health in a Non-Jaundiced Population of Children with Biliary Atresia. Gastroenterol Res Pract 2009;2009:1-9.
8. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4.
9. Roy A, Samanta T, Purkait R, et al. Etiology, clinical spectrum and outcome of metabolic liver diseases in children. J Coll Physicians Surg Pak 2013;23:194-8.
10. Salih MM, Ibraheem MF, Nader KE. Etiology and clinical pattern of liver diseases in children. J Fac Med Baghdad 2018;60:76-9.
11. Newton KP, Feldman HS, Chambers CD, et al. Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children. J Pediatr 2017;187:141-6.e1.
12. Barakat SH, El-Gendy W, Metwaly M. Chronic liver diseases in children: an aetiological study. Arch Dis Child 2008;93:pw565.
13. Hanif M, Raza J, Qureshi H, Issani Z. Etiology of chronic liver disease in children. J Pak Med Assoc 2004;54:119-22.
14. Pinto RB, Schneider AC, da Silveira TR. Cirrhosis in children and adolescents: An overview. World J Hepatol 2015;7:392-405.
15. Yazigi N, Balistreri WF. Viral hepatitis. In: Kliegman RM, Stanton BF, St. Gemelll JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 21St ed. Elsevier Saunders; 2019, pp. 1393-4.
16. Loomes KM, Spino C, Goodrich NP, et al. Bone density in children with chronic liver disease correlates with growth and cholestasis. Hepatology 2019;69:245-57.
17. H Krittapak, C Tawatchai, Udomsinprasert W, et al. Low bone mineral density and the severity of cholestasis in biliary atresia. World J Hepatol 2017;9:746-51.
18. Bales CB, Kamath BM, Munoz PS, et al. Pathologic Lower Extremity Fractures in Children with Alagille Syndrome. J Pediatr Gastroenterol Nutr 2010;51:66-70.
19. Chongsrisawat V, Ruttanamongko P, Chaiwatanarat T, et al. Bone density and 25-hydroxyvitamin D level in extrahepatic biliary atresia. Pediatr Surg Int 2001;17:604-8.

How to Cite



IMPACT OF CHRONIC LIVER DISEASE ON BONE DENSITY IN CHILDREN: A DEXA SCAN STUDY. (2026). EuroMediterranean Biomedical Journal, 21(2). https://doi.org/10.3269/jptjtx80
Copyright (c) 2026 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.